ENRICH Act 2026: Breaking Down the CBO Score and What $6.2B Over 10 Years Actually Means
Structured Data
- State / Federal Program
- ENRICH Act (Expanding Nutrition's Role in Improving Care for Health)
- Policy Area
- Medicare / Medicaid MTM and Produce Rx permanent benefit
- Relevant Agency
- Senate Finance Committee / CBO
- Effective Date
- Pending — markup targeted Q2/Q3 2026
- Summary
- Would establish permanent Medicare/Medicaid benefit for MTM and produce Rx. CBO scores net cost at $6.2B over 10 years.
- Potential Impact
- Could be the most significant federal FIM legislation since the ACA.
The Congressional Budget Office score for the ENRICH Act was released in March, and the $6.2B net cost estimate is going to be the central battleground in the markup. I want to break down what that number actually means — and why the offset projections may be the more important story.
The CBO Methodology
The $6.2B is the net cost after projected offsets from reduced hospitalizations and ER utilization. The gross spending number is approximately $11.4B over 10 years. CBO used conservative utilization assumptions — specifically, they assumed only 35% uptake among eligible beneficiaries in year one, ramping to 60% by year five.
Why the Offsets May Be Understated
The CBO score was completed before the MANNA and Second Harvest readmission data was available. If the 31% readmission reduction figure from the JAMA study is applied to even a portion of the eligible Medicare population, the offset calculation shifts substantially.
The Political Reality
With 19 Senate co-sponsors and a June markup timeline, the math needs to work for moderate Democrats and deficit-hawk Republicans. Advocates should be prepared to present the ROI case clearly and quantitatively.
Sources
https://www.congress.govAI Key Takeaways
AI Generated- 1ENRICH Act CBO score: $6.2B net cost over 10 years, after $5.2B in projected hospitalization offsets.
- 2CBO used conservative uptake assumptions (35% year-one) that pre-date the strongest readmission evidence.
- 3June markup timeline is aggressive — Q3 2026 more likely based on subcommittee staff signals.
- 4Advocates must present a clear quantitative ROI case to secure moderate Democratic and Republican votes.
Discussion 0 comments
and create account to join the discussion.
No comments yet. Start the discussion.
Thread Stats
This platform provides educational and policy discussion only and does not provide medical advice.
